Ranjit Kapadia
Feb 23, 2011 at 16:13 | Source: CNBC-TV18
Feb 23, 2011 at 16:10 | Source: CNBC-TV18
Jan 03, 2011 at 19:41 | Source: CNBC-TV18
Jan 03, 2011 at 19:36 | Source: CNBC-TV18
Nov 29, 2010 at 17:21 | Source: CNBC-TV18
Oct 21, 2010 at 15:33 | Source: CNBC-TV18
Interact & exchange stock tips & market info »
three times the growth in developed markets, says Centrum`s Ranjit...
11.59 AM Dec 20th 2011
Securities Vice President, Institutional Research Ranjit Ka...
5.10 PM Nov 23rd 2011
GlaxoSmithKline Pharmaceuticals took an 8 per cent hit in its bottom-l...
12.16 PM Nov 5th 2011
Related News »
The Decision Resources acquisition is interesting as it will give the company access to a huge database of medical information and help it make "informed decisions" in its research efforts, said Ranjit Kapadia, senior vice president at Mumbai ...
May 16, 2012 at 08:07 | Source: Smart Money
Firms such as Teva, Watson, Mylan and Sandoz compete with Indian drugmakers in the US and could tighten the field. “Even in niche categories, if the competition intensifies, prices could fall,” said Ranjit Kapadia, senior vice president, Centrum Broking.
May 25, 2012 at 03:25 | Source: Daily News and Analysis